| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.3 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |